RIL
CRMD icon

Rothschild Investment LLC’s CorMedix CRMD Stock Holding History

Rothschild Investment LLC’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$840 Buy
+107
New +$845 ﹤0.01% 3109
2025
Q4 		– Sell
-70
Closed -$814 – 3447
2025
Q3 		$814 Sell
70
-100
-59% -$1.21K ﹤0.01% 2669
2025
Q2 		$2.09K Buy
170
+50
+42% +$552 ﹤0.01% 2047
2025
Q1 		$739 Buy
120
+65
+118% +$673 ﹤0.01% 2493
2024
Q4 		$446 Buy
+55
New +$549 ﹤0.01% 2579

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Rothschild Investment LLC's CRMD Position: Q2 2026 in Review

Rothschild Investment LLC opened a new position in CorMedix (CRMD) in Q2 2026: 107 shares worth $840. The stake represents ﹤0.01% of the portfolio and ranks #3109 among its holdings. This is a return to the name: Rothschild Investment LLC previously reported a position in CRMD as recently as Q3 2025.

Rothschild Investment LLC first reported a position in CRMD in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.09K in Q2 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Rothschild Investment LLC held 107 shares of CorMedix worth $840 as of Q2 2026.
  • CorMedix was a new Rothschild Investment LLC position in Q2 2026.
  • CorMedix made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3109 holding.
  • Rothschild Investment LLC first reported a position in CorMedix in Q4 2024 and has held it in 5 quarters since.
  • Rothschild Investment LLC's CorMedix position peaked at $2.09K in Q2 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.